NEW YORK, Nov 19 (Reuters) - Bristol-Myers Squibb Co (BMY.N: Quote, Profile, Research) is poised to announce job cuts and plant closings as part of a major cost-cutting initiative, according to an analyst who introduced a short-term "buy" rating on the shares ahead of the drugmaker's meeting with analysts next month.
